NOTE: This bulletin is being recirculated to include the table of affected products
Reese Pharmaceutical Company Announces the Voluntary Nationwide Recall of Certain Over-The-Counter Cold Relief Products that are Mislabeled.
Fri, 10 Dec 2010 18:42:00 -0600
Reese Pharmaceutical Company of Cleveland, Ohio has voluntarily recalled lot# 091612 only in 60-count size bottles identified under four different brand names, listed in the table below, because cold decongestant tablets (containing Acetaminophen 325 mg, Phenylephrine 5 mg & Chlorpheniramine Maleate 2 mg) were mislabeled as containing only 200mg Guaifenesin tablets. This mislabeling could cause a consumer to ingest the product and unknowingly be exposed to serious side effects of acetaminophen, phenylephrine or chlorpheniramine.
| Product Name | NDC# | Lot# |
|
Refenesen Expectorant (guaifenesin 200 mg tablets)
|
10956-752-60; | 091612 05/11 SS/SCT36 06/26/09 |
|
Select Brand Mucus Relief Expectorant (guaifenesin 200 mg)
|
15127-129-60 | 091612 05/11 SS/SCT36 06/26/09 |
|
QC Medifin Expectorant (guaifenesin 200 mg)
|
63868-754-60 | 091612 05/11 SS/SCT36 06/26/09 |
|
Leader Cough Tabs Expectorant (guaifenesin 200 mg)
|
37205-466-72 | 091612 05/11 SS/SCT36 06/26/09 |
Manage your FDA Subscriptions:
- Update your preferences or unsubscribe
- Questions about this service? support@xxxxxxxxxxxxxxx
- Other inquiries? webmail@xxxxxxxxxx
U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 800-439-1420
